UNSPSC 51402310: Tandospirone citrate

This classification denotes a serotonin agonist and anxiolytic with the molecular formula C21H29N5O2.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0R8E9BWM4J, chemically known as 4,7-methano-1h-isoindole-1,3(2h)-dione, hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, (3aalpha,4beta,7beta,7aalpha)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) but more generally known as tandospirone citrate, which bears US NIH Compound Identifier 60558.

UNSPSC 51402310 Tandospirone citrate is a Commodity code that nominally designates a specific pharmaceutical active ingredient, yet the single recent state and local opportunity tagged under it shows a significant mismatch: Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023) for naloxone and drug deactivation systems—emergency overdose-reversal medications and harm-reduction equipment, not tandospirone citrate, an anxiolytic rarely procured through state and local channels. The code shows minimal recent activity relevant to its nominal scope. State and local procurement under this code does not appear to reflect routine pharmaceutical supply chains; instead, the single visible opportunity reflects community health and public safety initiatives centered on opioid-crisis response infrastructure.

Seminole County, Florida remains the only identifiable recent issuing body under this code in the dataset. The county's IFB sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors were required to submit electronic bids, include all shipping and delivery costs, comply with drug-free workplace and E-Verify requirements, maintain workers' compensation and general liability insurance, and accept a three-month probationary termination clause. The contract carried a two-year initial term with a one-year renewal option and was potentially FEMA-funded, triggering federal environmental and compliance audits. The mismatch between the code's pharmaceutical designation and the actual procurement—focused on emergency-response medications and systems—signals either a coding error in the source or extremely limited state and local use of this code tier for its nominal product. Firms should verify coding accuracy before pursuing activity under this designation.